IN2012DN01929A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01929A
IN2012DN01929A IN1929DEN2012A IN2012DN01929A IN 2012DN01929 A IN2012DN01929 A IN 2012DN01929A IN 1929DEN2012 A IN1929DEN2012 A IN 1929DEN2012A IN 2012DN01929 A IN2012DN01929 A IN 2012DN01929A
Authority
IN
India
Prior art keywords
pure
preparation
provides
present
novel process
Prior art date
Application number
Inventor
Salman Hashmi Mohammed
Kumar Sharma Mukesh
Has Khanduri Chandra
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of IN2012DN01929A publication Critical patent/IN2012DN01929A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Abstract

The present invention provides a novel process for the preparation of pure Valganciclovir hydrochloride.
IN1929DEN2012 2009-08-12 2010-08-12 IN2012DN01929A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1683DE2009 2009-08-12
PCT/IB2010/053657 WO2011018771A2 (en) 2009-08-12 2010-08-12 Process for the preparation of valganciclovir hydrochloride

Publications (1)

Publication Number Publication Date
IN2012DN01929A true IN2012DN01929A (en) 2015-07-24

Family

ID=43533530

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1929DEN2012 IN2012DN01929A (en) 2009-08-12 2010-08-12

Country Status (3)

Country Link
US (1) US8586738B2 (en)
IN (1) IN2012DN01929A (en)
WO (1) WO2011018771A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100298564A1 (en) * 2009-05-25 2010-11-25 Venu Nalivela Preparation of amorphous valganciclovir hydrochloride
CN104749286B (en) * 2015-04-14 2017-03-08 湖北丽益医药科技有限公司 A kind of analyzing detecting method of valganciclovir hydrochloride impurity
CN107163050B (en) * 2017-07-10 2018-03-30 湖北天义药业有限公司 A kind of synthetic method of valganciclovir hydrochloride
CN111763207A (en) * 2019-04-02 2020-10-13 北京万全德众医药生物技术有限公司 Preparation method of valganciclovir hydrochloride
CN110988246B (en) * 2019-11-29 2022-03-08 荆门医药工业技术研究院 Method for detecting contents of Z-L-valine and intermediate (S) -4-isopropyloxazole-2, 5-diketone thereof
CN113933413B (en) * 2021-09-27 2024-03-12 武汉九州钰民医药科技有限公司 Method for detecting impurity K in ganciclovir and method for separating impurity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083953A (en) 1994-07-28 2000-07-04 Syntex (U.S.A.) Inc. 2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
WO2005092891A2 (en) 2004-03-29 2005-10-06 Ranbaxy Laboratories Limited Preparation of esters of ganciclovir

Also Published As

Publication number Publication date
WO2011018771A3 (en) 2011-05-12
US8586738B2 (en) 2013-11-19
US20120190850A1 (en) 2012-07-26
WO2011018771A2 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
IL242751B (en) Processes for preparing jak inhibitors
PT2913337T (en) Process for the production of sofosbuvir
ZA201200409B (en) Compounds for the reduction of b-amyloid production
MX2010009003A (en) Cyclohexanedimethanamine by direct amination of cyclohexanedimethanol.
TN2011000673A1 (en) Bace inhibitors
ZA201202504B (en) Process for the preparation of calcobutrol
IN2014CN04160A (en)
PL2398808T3 (en) Process for the reductive alkylation of normorphinans
PL390042A1 (en) Process for the preparation of kvass
IL216942A0 (en) Process for the manufacture of alkenones
IN2012DN01929A (en)
TW200833649A (en) Method for the preparation of hydroxyadamantanamine
IL214437A0 (en) Process for the synthesis of cleistanthin
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.
PL388931A1 (en) Process for the preparation of fluorocarbfunctional silesquioxanes
IN2014DN09451A (en)
UA110626C2 (en) Process for preparing pan-cdk inhibitors of the formula (i), and also to intermediates in the preparation
WO2014064714A3 (en) Process for preparation of lurasidone hydrochloride
MX337610B (en) Processes for the preparation of (r)-2-acetamido-n-benzyl- 3-methoxypropionamide and intermediates thereof.
MX345822B (en) Separation of triazine derivatives enantiomers using tartaric acid.
MX2013002395A (en) Method for producing dithiin-tetracarboximides.
PL2435447T3 (en) Process for the manufacture of dialkylphosphites
IN2012DN01846A (en)
MX2009003196A (en) Process for the preparation of î³-butyrolactones.
IN2012DN00346A (en)